These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30028623)

  • 1. Bioengineered Macrophages Can Responsively Transform into Nanovesicles To Target Lung Metastasis.
    Cao H; Wang H; He X; Tan T; Hu H; Wang Z; Wang J; Li J; Zhang Z; Li Y
    Nano Lett; 2018 Aug; 18(8):4762-4770. PubMed ID: 30028623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory Monocytes Loading Protease-Sensitive Nanoparticles Enable Lung Metastasis Targeting and Intelligent Drug Release for Anti-Metastasis Therapy.
    He X; Cao H; Wang H; Tan T; Yu H; Zhang P; Yin Q; Zhang Z; Li Y
    Nano Lett; 2017 Sep; 17(9):5546-5554. PubMed ID: 28758755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoformulation of dual bexarotene-tailed phospholipid conjugate with high drug loading.
    He R; Du Y; Ling L; Ismail M; Hou Y; Yao C; Li X
    Eur J Pharm Sci; 2017 Mar; 100():197-204. PubMed ID: 28088372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial-Drug-Laden Protease-Activatable M1 Macrophage System Targets Lung Metastasis and Potentiates Antitumor Immunity.
    Xu X; Wang Q; Qian X; Wu Y; Wang J; Li J; Li Y; Zhang Z
    ACS Nano; 2023 Mar; 17(6):5354-5372. PubMed ID: 36877635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective self-induced stimulus amplification prodrug platform for inhibiting multidrug resistance and lung metastasis.
    Xu C; Sun Y; Qi Y; Yu Y; He Y; Hu M; Hu Q; Wu T; Zhang D; Shang L; Deng H; Zhang Z
    J Control Release; 2018 Aug; 284():224-239. PubMed ID: 29958912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy.
    Wang G; Wang Z; Li C; Duan G; Wang K; Li Q; Tao T
    Biomed Pharmacother; 2018 Oct; 106():275-284. PubMed ID: 29966971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonate-functionalized coordination polymer nanoparticles for the treatment of bone metastatic breast cancer.
    He Y; Huang Y; Huang Z; Jiang Y; Sun X; Shen Y; Chu W; Zhao C
    J Control Release; 2017 Oct; 264():76-88. PubMed ID: 28842315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease-mediated release of chemotherapeutics from mesoporous silica nanoparticles to ex vivo human and mouse lung tumors.
    van Rijt SH; Bölükbas DA; Argyo C; Datz S; Lindner M; Eickelberg O; Königshoff M; Bein T; Meiners S
    ACS Nano; 2015 Mar; 9(3):2377-89. PubMed ID: 25703655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging-Guided Drug Release from Glutathione-Responsive Supramolecular Porphysome Nanovesicles.
    Xu XD; Zhao L; Qu Q; Wang JG; Shi H; Zhao Y
    ACS Appl Mater Interfaces; 2015 Aug; 7(31):17371-80. PubMed ID: 26186168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-derived nanovesicles promote lung distribution of the therapeutic nanovector through repression of Kupffer cell-mediated phagocytosis.
    Qiu X; Li Z; Han X; Zhen L; Luo C; Liu M; Yu K; Ren Y
    Theranostics; 2019; 9(9):2618-2636. PubMed ID: 31131057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of molecular structure on the anticancer drug release rate from prodrug nanoparticles.
    Ikuta Y; Koseki Y; Onodera T; Oikawa H; Kasai H
    Chem Commun (Camb); 2015 Aug; 51(64):12835-8. PubMed ID: 26165183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoplasmic reticulum-targeted glutathione and pH dual responsive vitamin lipid nanovesicles for tocopheryl DM1 delivery and cancer therapy.
    Wang YQ; Ji MY; Wang C
    Int J Pharm; 2020 May; 582():119331. PubMed ID: 32289484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual Chemodrug-Loaded Single-Walled Carbon Nanohorns for Multimodal Imaging-Guided Chemo-Photothermal Therapy of Tumors and Lung Metastases.
    Yang J; Su H; Sun W; Cai J; Liu S; Chai Y; Zhang C
    Theranostics; 2018; 8(7):1966-1984. PubMed ID: 29556368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial protoplast-derived nanovesicles for tumor targeted delivery of chemotherapeutics.
    Kim OY; Dinh NT; Park HT; Choi SJ; Hong K; Gho YS
    Biomaterials; 2017 Jan; 113():68-79. PubMed ID: 27810643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-conjugated mesoporous silica nanorattles based on enzyme targeted prodrug delivery system for effective lung cancer therapy.
    Sundarraj S; Thangam R; Sujitha MV; Vimala K; Kannan S
    Toxicol Appl Pharmacol; 2014 Mar; 275(3):232-43. PubMed ID: 24467950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors.
    Jang SC; Kim OY; Yoon CM; Choi DS; Roh TY; Park J; Nilsson J; Lötvall J; Kim YK; Gho YS
    ACS Nano; 2013 Sep; 7(9):7698-710. PubMed ID: 24004438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial Targeting of Tumor-Associated Macrophages and Tumor Cells with a pH-Sensitive Cluster Nanocarrier for Cancer Chemoimmunotherapy.
    Shen S; Li HJ; Chen KG; Wang YC; Yang XZ; Lian ZX; Du JZ; Wang J
    Nano Lett; 2017 Jun; 17(6):3822-3829. PubMed ID: 28488871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting cell surface alpha(v)beta(3) integrin increases therapeutic efficacies of a legumain protease-activated auristatin prodrug.
    Liu Y; Bajjuri KM; Liu C; Sinha SC
    Mol Pharm; 2012 Jan; 9(1):168-75. PubMed ID: 22044266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Composite alkali polysaccharide supramolecular nanovesicles improve biocharacteristics and anti-lung cancer activity of natural phenolic drugs via oral administration.
    Huang Y; Hu X; Zhao H; He D; Li Y; Yang M; Yu Z; Li K; Zhang J
    Int J Pharm; 2020 Jan; 573():118864. PubMed ID: 31765782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed Progression of Lung Metastases Following Delivery of a Prodrug-activating Enzyme.
    Dore-Savard L; Chen Z; Winnard PT; Krishnamachary B; Raman V; Black ME; Bhujwalla ZM
    Anticancer Res; 2017 May; 37(5):2195-2200. PubMed ID: 28476782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.